134865-55-7 Usage
Description
(E)-N-(3-chloropropenyl)-N-ethyl-3-hydroxybenzylamine is a chemical compound that belongs to the class of benzylamine derivatives. It is composed of an ethyl group attached to the nitrogen atom, a hydroxybenzyl group, and a 3-chloropropenyl group. (E)-N-(3-chloropropenyl)-N-ethyl-3-hydroxybenzylamine has potential applications in the pharmaceutical industry, particularly as a building block for the synthesis of various organic compounds. It may also exhibit biological activities, although further research is needed to fully understand its potential uses.
Uses
Used in Pharmaceutical Industry:
(E)-N-(3-chloropropenyl)-N-ethyl-3-hydroxybenzylamine is used as a building block for the synthesis of various organic compounds, which can be further utilized in the development of pharmaceuticals. Its unique structure and potential biological activities make it a promising candidate for creating new drugs and therapeutic agents.
Used in Chemical Synthesis:
In the field of chemical synthesis, (E)-N-(3-chloropropenyl)-N-ethyl-3-hydroxybenzylamine can be used as a key intermediate in the production of a range of chemical products. Its versatility in forming different types of chemical bonds allows for the creation of a variety of compounds with diverse applications.
Check Digit Verification of cas no
The CAS Registry Mumber 134865-55-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,4,8,6 and 5 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 134865-55:
(8*1)+(7*3)+(6*4)+(5*8)+(4*6)+(3*5)+(2*5)+(1*5)=147
147 % 10 = 7
So 134865-55-7 is a valid CAS Registry Number.
134865-55-7Relevant articles and documents
(Aryloxy)methylsilane Derivatives as New Cholesterol Biosynthesis Inhibitors: Synthesis and Hypocholesterolemic Activity of a New Class of Squalene Epoxidase Inhibitors
Gotteland, Jean-Pierre,Brunel Isabelle,Gendre, Fabrice,Desire, Jerome,Delhon, Andre,at al.
, p. 3207 - 3216 (2007/10/03)
A series of 3-substituted (aryloxy)silane derivatives of benzylamine (4' 4', or 4") was synthesized and evaluated for hypocholesterolemic activity.Most of the new silane derivatives were identified as potent inhibitors of pig liver squalene epoxidase with
